AGPS and Scheie syndrome: More than 90% of MPS I patients developed antibodies to laronidase during the first few months of treatment [12], about 50% of MPS II patients produced antibodies against idursulphase [22], and almost all patients treated with elosulphase [87] and galsulphase [88] produced ADAs.